| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin Class Switching | 26 | 2017 | 291 | 2.640 |
Why?
|
| B-Lymphocytes | 36 | 2020 | 4665 | 1.200 |
Why?
|
| Immunoglobulin Heavy Chains | 17 | 2015 | 659 | 1.010 |
Why?
|
| Recombination, Genetic | 18 | 2011 | 1586 | 0.920 |
Why?
|
| Cytidine Deaminase | 13 | 2015 | 252 | 0.800 |
Why?
|
| Anemia, Sickle Cell | 5 | 2021 | 1018 | 0.750 |
Why?
|
| DNA Repair | 18 | 2015 | 2046 | 0.740 |
Why?
|
| Hematopoietic Stem Cells | 8 | 2021 | 3386 | 0.720 |
Why?
|
| Blood Platelets | 2 | 2022 | 2508 | 0.640 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 2015 | 223 | 0.550 |
Why?
|
| DNA-Binding Proteins | 24 | 2016 | 9648 | 0.520 |
Why?
|
| DNA Polymerase II | 1 | 2015 | 107 | 0.510 |
Why?
|
| Immunoglobulin Constant Regions | 4 | 2015 | 59 | 0.490 |
Why?
|
| Transplantation Conditioning | 1 | 2021 | 1598 | 0.470 |
Why?
|
| gamma-Globins | 4 | 2022 | 95 | 0.440 |
Why?
|
| Platelet Transfusion | 1 | 2016 | 314 | 0.440 |
Why?
|
| DNA Damage | 12 | 2010 | 2432 | 0.410 |
Why?
|
| Nuclear Proteins | 15 | 2022 | 5853 | 0.400 |
Why?
|
| Genes, Immunoglobulin | 5 | 2003 | 291 | 0.390 |
Why?
|
| Chromosome Breakage | 4 | 2008 | 173 | 0.380 |
Why?
|
| YY1 Transcription Factor | 1 | 2011 | 60 | 0.380 |
Why?
|
| Germinal Center | 3 | 2020 | 377 | 0.370 |
Why?
|
| Fetal Hemoglobin | 3 | 2022 | 341 | 0.370 |
Why?
|
| Antigens, Nuclear | 5 | 2010 | 192 | 0.360 |
Why?
|
| DNA Breaks, Double-Stranded | 6 | 2015 | 594 | 0.350 |
Why?
|
| Translocation, Genetic | 8 | 2008 | 1420 | 0.350 |
Why?
|
| Immunoglobulin E | 5 | 2017 | 1463 | 0.350 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 246 | 0.350 |
Why?
|
| Lymphopoiesis | 3 | 2018 | 135 | 0.330 |
Why?
|
| DNA Breaks | 1 | 2008 | 49 | 0.320 |
Why?
|
| Mice, Knockout | 25 | 2016 | 14557 | 0.310 |
Why?
|
| Mutation | 16 | 2018 | 29786 | 0.310 |
Why?
|
| Nobel Prize | 1 | 2007 | 49 | 0.300 |
Why?
|
| Mice | 60 | 2022 | 81183 | 0.280 |
Why?
|
| Tumor Suppressor Protein p53 | 13 | 2008 | 2948 | 0.280 |
Why?
|
| Lymphoma | 3 | 2011 | 1877 | 0.250 |
Why?
|
| Immunoglobulin mu-Chains | 2 | 2011 | 62 | 0.250 |
Why?
|
| Genetic Techniques | 1 | 2007 | 435 | 0.250 |
Why?
|
| STAT3 Transcription Factor | 3 | 2018 | 873 | 0.250 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5442 | 0.240 |
Why?
|
| Lymphoma, B-Cell | 9 | 2010 | 931 | 0.240 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2017 | 212 | 0.230 |
Why?
|
| Animals | 68 | 2022 | 168757 | 0.230 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2012 | 2849 | 0.230 |
Why?
|
| DNA-Activated Protein Kinase | 5 | 2014 | 117 | 0.230 |
Why?
|
| Hypergammaglobulinemia | 1 | 2003 | 74 | 0.230 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2023 | 60 | 0.230 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2017 | 547 | 0.220 |
Why?
|
| Immunoglobulin Switch Region | 4 | 2010 | 46 | 0.220 |
Why?
|
| Immunoglobulin M | 4 | 2010 | 1537 | 0.220 |
Why?
|
| Mice, Mutant Strains | 5 | 2016 | 1866 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4479 | 0.210 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 4 | 2008 | 111 | 0.210 |
Why?
|
| Repressor Proteins | 4 | 2022 | 3023 | 0.210 |
Why?
|
| Cell Differentiation | 11 | 2018 | 11483 | 0.210 |
Why?
|
| Freeze Drying | 1 | 2022 | 98 | 0.210 |
Why?
|
| Hemoglobinopathies | 1 | 2022 | 96 | 0.200 |
Why?
|
| Phosphoproteins | 3 | 2006 | 2440 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2009 | 2915 | 0.190 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2017 | 581 | 0.190 |
Why?
|
| DNA Helicases | 4 | 2000 | 859 | 0.190 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 4 | 2007 | 97 | 0.190 |
Why?
|
| Lymphocytes | 6 | 2017 | 2617 | 0.190 |
Why?
|
| Focal Adhesion Kinase 1 | 2 | 2012 | 120 | 0.180 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1294 | 0.180 |
Why?
|
| Cell Cycle Proteins | 5 | 2012 | 3462 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 2 | 2018 | 227 | 0.180 |
Why?
|
| Genes, RAG-1 | 2 | 2018 | 68 | 0.180 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 3 | 2008 | 57 | 0.170 |
Why?
|
| Reed-Sternberg Cells | 1 | 1999 | 73 | 0.170 |
Why?
|
| DNA Ligases | 3 | 2014 | 80 | 0.170 |
Why?
|
| Protein Phosphatase 2 | 1 | 2020 | 229 | 0.160 |
Why?
|
| Flow Cytometry | 10 | 2020 | 5974 | 0.160 |
Why?
|
| Blood Component Removal | 1 | 2018 | 125 | 0.150 |
Why?
|
| Histones | 5 | 2015 | 2599 | 0.150 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 249 | 0.150 |
Why?
|
| Immunoglobulin G | 6 | 2014 | 4560 | 0.150 |
Why?
|
| Lymphocyte Activation | 8 | 2020 | 5524 | 0.150 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 971 | 0.150 |
Why?
|
| Immunoglobulin Light Chains | 3 | 2005 | 277 | 0.150 |
Why?
|
| Carrier Proteins | 5 | 2022 | 5021 | 0.140 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2016 | 68 | 0.140 |
Why?
|
| Genomic Instability | 4 | 2016 | 695 | 0.140 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2016 | 56 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 12072 | 0.140 |
Why?
|
| Neutropenia | 1 | 2021 | 895 | 0.140 |
Why?
|
| Bone Diseases, Developmental | 1 | 2017 | 130 | 0.140 |
Why?
|
| Immunoglobulin epsilon-Chains | 2 | 2014 | 16 | 0.140 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2017 | 171 | 0.130 |
Why?
|
| Bone Marrow | 2 | 2018 | 2948 | 0.130 |
Why?
|
| Endodeoxyribonucleases | 1 | 2016 | 165 | 0.130 |
Why?
|
| Homeodomain Proteins | 4 | 2016 | 2421 | 0.130 |
Why?
|
| Immunoglobulin Isotypes | 3 | 2002 | 158 | 0.130 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2016 | 127 | 0.130 |
Why?
|
| Heterozygote | 4 | 2016 | 2804 | 0.130 |
Why?
|
| Agammaglobulinemia | 1 | 1996 | 167 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1341 | 0.130 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 9734 | 0.130 |
Why?
|
| Endonucleases | 5 | 2015 | 380 | 0.130 |
Why?
|
| T-Lymphocytes | 7 | 2020 | 10180 | 0.120 |
Why?
|
| Pneumococcal Vaccines | 1 | 2018 | 391 | 0.120 |
Why?
|
| I-kappa B Proteins | 1 | 2015 | 225 | 0.120 |
Why?
|
| Vaccines | 1 | 2022 | 822 | 0.120 |
Why?
|
| Erythrocytes | 1 | 2023 | 2455 | 0.120 |
Why?
|
| Sequence Deletion | 4 | 2015 | 1526 | 0.120 |
Why?
|
| Pneumococcal Infections | 1 | 2018 | 497 | 0.110 |
Why?
|
| Organogenesis | 1 | 2015 | 222 | 0.110 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 455 | 0.110 |
Why?
|
| Intestinal Atresia | 1 | 2013 | 68 | 0.110 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 1072 | 0.110 |
Why?
|
| Cells, Cultured | 13 | 2020 | 19229 | 0.110 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2012 | 49 | 0.110 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 2002 | 193 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 315 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 6 | 2008 | 2649 | 0.100 |
Why?
|
| RNA Interference | 1 | 2020 | 2889 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2012 | 1861 | 0.100 |
Why?
|
| DNA Mutational Analysis | 3 | 2015 | 4186 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2018 | 766 | 0.100 |
Why?
|
| Alleles | 6 | 2018 | 6933 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2014 | 571 | 0.100 |
Why?
|
| Humans | 43 | 2023 | 744343 | 0.100 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2012 | 160 | 0.100 |
Why?
|
| 5' Flanking Region | 1 | 2010 | 31 | 0.100 |
Why?
|
| Hodgkin Disease | 1 | 1999 | 1415 | 0.100 |
Why?
|
| Precursor Cells, B-Lymphoid | 2 | 2010 | 98 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2015 | 1850 | 0.090 |
Why?
|
| Neutrophils | 2 | 2021 | 3719 | 0.090 |
Why?
|
| Trans-Activators | 3 | 2012 | 2924 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 565 | 0.090 |
Why?
|
| Deoxyribonuclease I | 1 | 2010 | 229 | 0.090 |
Why?
|
| Genes, Regulator | 2 | 2003 | 378 | 0.090 |
Why?
|
| Gene Conversion | 2 | 2016 | 71 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 13 | 2018 | 21827 | 0.090 |
Why?
|
| Gene Rearrangement | 4 | 2003 | 1179 | 0.080 |
Why?
|
| Chromosome Aberrations | 3 | 2007 | 1813 | 0.080 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 2 | 1999 | 113 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 1456 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 893 | 0.080 |
Why?
|
| Chromosome Pairing | 1 | 2007 | 47 | 0.080 |
Why?
|
| Phosphorylation | 7 | 2015 | 8436 | 0.080 |
Why?
|
| beta-Thalassemia | 2 | 2020 | 225 | 0.070 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2007 | 175 | 0.070 |
Why?
|
| Apoptosis | 8 | 2018 | 9727 | 0.070 |
Why?
|
| Base Sequence | 8 | 2019 | 12797 | 0.070 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2017 | 1736 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 186 | 0.070 |
Why?
|
| Immunoglobulins | 1 | 2010 | 881 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2007 | 373 | 0.070 |
Why?
|
| VDJ Recombinases | 2 | 2002 | 84 | 0.070 |
Why?
|
| Immunophenotyping | 3 | 2018 | 1880 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2008 | 527 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2012 | 1348 | 0.060 |
Why?
|
| Thymus Neoplasms | 2 | 2006 | 268 | 0.060 |
Why?
|
| Serine | 1 | 2009 | 826 | 0.060 |
Why?
|
| HIV-1 | 1 | 2022 | 6939 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2002 | 2716 | 0.060 |
Why?
|
| Genetic Vectors | 2 | 2020 | 3420 | 0.060 |
Why?
|
| Lysine | 1 | 2009 | 1007 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2008 | 3494 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2014 | 1682 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 2133 | 0.060 |
Why?
|
| Genes, myc | 2 | 2004 | 399 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2007 | 548 | 0.060 |
Why?
|
| Cell Cycle | 5 | 2014 | 2967 | 0.060 |
Why?
|
| Child, Preschool | 6 | 2017 | 41006 | 0.060 |
Why?
|
| Intestines | 1 | 2013 | 1924 | 0.060 |
Why?
|
| Autoantibodies | 3 | 2020 | 2035 | 0.060 |
Why?
|
| Rho(D) Immune Globulin | 1 | 2023 | 34 | 0.060 |
Why?
|
| VDJ Exons | 2 | 2015 | 11 | 0.060 |
Why?
|
| Suppression, Genetic | 1 | 2004 | 196 | 0.060 |
Why?
|
| Plasma Cells | 2 | 2010 | 591 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2005 | 491 | 0.060 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2022 | 64 | 0.060 |
Why?
|
| Transcription Factors | 4 | 2022 | 12208 | 0.050 |
Why?
|
| Phenotype | 6 | 2018 | 16365 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2007 | 726 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2007 | 1252 | 0.050 |
Why?
|
| Complementarity Determining Regions | 1 | 2022 | 149 | 0.050 |
Why?
|
| Genes, Switch | 1 | 2002 | 47 | 0.050 |
Why?
|
| Interleukin-4 | 2 | 2017 | 1147 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2016 | 418 | 0.050 |
Why?
|
| Leukocyte Transfusion | 1 | 2021 | 60 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2007 | 1534 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2004 | 755 | 0.050 |
Why?
|
| Cell Count | 2 | 2018 | 1856 | 0.050 |
Why?
|
| Ubiquitination | 3 | 2012 | 1012 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2008 | 2942 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3870 | 0.050 |
Why?
|
| Isoantigens | 1 | 2023 | 567 | 0.050 |
Why?
|
| Radiation, Ionizing | 2 | 2015 | 258 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 4 | 2014 | 6386 | 0.050 |
Why?
|
| beta-Lactamases | 1 | 2002 | 306 | 0.050 |
Why?
|
| Sirtuins | 1 | 2003 | 323 | 0.050 |
Why?
|
| Gene Targeting | 2 | 2020 | 880 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 2007 | 7722 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3703 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 4838 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 903 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2023 | 679 | 0.040 |
Why?
|
| Locus Control Region | 1 | 1999 | 20 | 0.040 |
Why?
|
| Proteins | 2 | 2013 | 6103 | 0.040 |
Why?
|
| Lentivirus | 1 | 2022 | 501 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 2216 | 0.040 |
Why?
|
| DNA Primers | 3 | 2010 | 2892 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 1276 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2021 | 648 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2003 | 707 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 17446 | 0.040 |
Why?
|
| Cell Line | 5 | 2014 | 15997 | 0.040 |
Why?
|
| Erythroid Precursor Cells | 1 | 2019 | 218 | 0.040 |
Why?
|
| Fetal Death | 1 | 2000 | 448 | 0.040 |
Why?
|
| Biological Transport, Active | 2 | 1970 | 349 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2020 | 657 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 279 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2002 | 1063 | 0.040 |
Why?
|
| Globins | 1 | 1998 | 415 | 0.040 |
Why?
|
| Benzylamines | 1 | 2018 | 223 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 2916 | 0.040 |
Why?
|
| Oncogenes | 1 | 2003 | 1265 | 0.040 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 1378 | 0.040 |
Why?
|
| Cell Division | 2 | 2002 | 4568 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 9438 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2016 | 3128 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 4751 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2014 | 7880 | 0.040 |
Why?
|
| Radiation Tolerance | 2 | 2015 | 486 | 0.040 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2018 | 272 | 0.040 |
Why?
|
| Syndrome | 1 | 2003 | 3251 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2020 | 3505 | 0.040 |
Why?
|
| Chromatids | 1 | 2016 | 63 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 6171 | 0.040 |
Why?
|
| Male | 13 | 2020 | 350118 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2014 | 23403 | 0.040 |
Why?
|
| Poly I-C | 1 | 2016 | 115 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2020 | 8324 | 0.040 |
Why?
|
| HIV Infections | 1 | 2022 | 16718 | 0.030 |
Why?
|
| Cell Survival | 2 | 2018 | 5882 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2015 | 736 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2017 | 708 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2019 | 13815 | 0.030 |
Why?
|
| Deamination | 1 | 2015 | 26 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1655 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 2022 | 1322 | 0.030 |
Why?
|
| Heparitin Sulfate | 1 | 2017 | 225 | 0.030 |
Why?
|
| Cell Death | 1 | 2021 | 1706 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2009 | 905 | 0.030 |
Why?
|
| Zygote | 1 | 2016 | 116 | 0.030 |
Why?
|
| Oncogene Proteins v-abl | 1 | 2015 | 22 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2020 | 2124 | 0.030 |
Why?
|
| Hybridomas | 2 | 2010 | 452 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 2505 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1878 | 0.030 |
Why?
|
| Antibodies | 1 | 2023 | 2460 | 0.030 |
Why?
|
| Tumor Necrosis Factors | 1 | 2015 | 109 | 0.030 |
Why?
|
| Antibody Formation | 2 | 2015 | 1402 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 328 | 0.030 |
Why?
|
| Dermatitis, Contact | 1 | 2015 | 129 | 0.030 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 2014 | 33 | 0.030 |
Why?
|
| Genome | 2 | 2000 | 1808 | 0.030 |
Why?
|
| Thymus Gland | 2 | 2013 | 1267 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2023 | 2258 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2003 | 3206 | 0.030 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2015 | 484 | 0.030 |
Why?
|
| Female | 13 | 2023 | 380194 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 18029 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 598 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 898 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2023 | 25625 | 0.030 |
Why?
|
| Phenylenediamines | 1 | 2014 | 90 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 3002 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 386 | 0.030 |
Why?
|
| X Chromosome | 1 | 1996 | 814 | 0.030 |
Why?
|
| Neoplasms | 4 | 2003 | 21683 | 0.030 |
Why?
|
| Codon | 1 | 2015 | 611 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 1978 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 2014 | 245 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 2012 | 121 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10481 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 275 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2018 | 714 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2012 | 356 | 0.030 |
Why?
|
| Histone Chaperones | 1 | 2012 | 76 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 1723 | 0.030 |
Why?
|
| Catalysis | 1 | 2014 | 761 | 0.030 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2012 | 86 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2012 | 142 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2002 | 4026 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2020 | 1349 | 0.030 |
Why?
|
| Intestine, Small | 2 | 1970 | 1241 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3920 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2008 | 2256 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2016 | 794 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 553 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2020 | 2104 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 592 | 0.020 |
Why?
|
| Fibroblasts | 3 | 2014 | 4161 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 1782 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1996 | 2421 | 0.020 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2011 | 93 | 0.020 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 1970 | 15 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 440 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2010 | 92 | 0.020 |
Why?
|
| Rodent Diseases | 1 | 1970 | 57 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2012 | 464 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2012 | 285 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
| Iron | 2 | 1970 | 1774 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2016 | 1149 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 675 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2012 | 551 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2010 | 803 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 20822 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2018 | 2072 | 0.020 |
Why?
|
| Infant | 3 | 2017 | 35136 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 443 | 0.020 |
Why?
|
| Adolescent | 4 | 2020 | 85781 | 0.020 |
Why?
|
| Peyer's Patches | 1 | 2009 | 121 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 18111 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2009 | 290 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56430 | 0.020 |
Why?
|
| Autoantigens | 1 | 2012 | 892 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 11366 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4204 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2007 | 475 | 0.020 |
Why?
|
| Duodenum | 2 | 1970 | 483 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2010 | 794 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 2699 | 0.020 |
Why?
|
| Methylation | 1 | 2009 | 1106 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 1085 | 0.020 |
Why?
|
| Phenylhydrazines | 1 | 1966 | 28 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 1838 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 6622 | 0.020 |
Why?
|
| Inflammation | 2 | 2003 | 10638 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| Survival Rate | 3 | 2006 | 12788 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2009 | 494 | 0.020 |
Why?
|
| Replication Protein A | 1 | 2005 | 52 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3846 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2006 | 151 | 0.020 |
Why?
|
| Zebrafish | 1 | 2017 | 2994 | 0.020 |
Why?
|
| Protein Binding | 2 | 2009 | 9386 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2503 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2009 | 670 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2014 | 2504 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6365 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 707 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2009 | 852 | 0.020 |
Why?
|
| Child | 3 | 2020 | 77709 | 0.010 |
Why?
|
| Neurons | 2 | 2000 | 9338 | 0.010 |
Why?
|
| Leukemia, B-Cell | 1 | 2004 | 86 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2013 | 13033 | 0.010 |
Why?
|
| Metformin | 1 | 2010 | 835 | 0.010 |
Why?
|
| Sirtuin 2 | 1 | 2003 | 97 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 987 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2009 | 2234 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2437 | 0.010 |
Why?
|
| Cytosol | 1 | 2006 | 901 | 0.010 |
Why?
|
| Infertility, Male | 1 | 2006 | 409 | 0.010 |
Why?
|
| Infrared Rays | 1 | 2003 | 249 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21746 | 0.010 |
Why?
|
| Erythropoiesis | 1 | 1966 | 705 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2002 | 878 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 318 | 0.010 |
Why?
|
| Binding Sites | 1 | 2010 | 6114 | 0.010 |
Why?
|
| Genotype | 2 | 2010 | 12951 | 0.010 |
Why?
|
| Homeostasis | 1 | 2012 | 3340 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 1990 | 0.010 |
Why?
|
| Karyotyping | 1 | 2003 | 1243 | 0.010 |
Why?
|
| Telomere | 1 | 2007 | 910 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2007 | 1076 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2007 | 3144 | 0.010 |
Why?
|
| Anemia | 1 | 1970 | 1506 | 0.010 |
Why?
|
| Polyomavirus | 1 | 2001 | 248 | 0.010 |
Why?
|
| Chimera | 1 | 2001 | 485 | 0.010 |
Why?
|
| Adult | 3 | 2020 | 214055 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 1097 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 1785 | 0.010 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1999 | 68 | 0.010 |
Why?
|
| Neomycin | 1 | 1999 | 88 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2000 | 242 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 5892 | 0.010 |
Why?
|
| Chromosomes | 1 | 2002 | 596 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2002 | 805 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4554 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 7799 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2004 | 8428 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2000 | 705 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 9274 | 0.010 |
Why?
|
| Growth | 1 | 1999 | 376 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4320 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 655 | 0.010 |
Why?
|
| Antigens | 1 | 2001 | 1466 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 4740 | 0.010 |
Why?
|
| Nervous System | 1 | 1999 | 554 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1701 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16689 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 1997 | 570 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2000 | 1184 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 2751 | 0.010 |
Why?
|
| Chromatin | 1 | 2003 | 2934 | 0.010 |
Why?
|
| Iron Isotopes | 1 | 1970 | 19 | 0.010 |
Why?
|
| Serous Membrane | 1 | 1970 | 28 | 0.010 |
Why?
|
| Haploidy | 1 | 1970 | 136 | 0.010 |
Why?
|
| Sex Chromosomes | 1 | 1970 | 105 | 0.010 |
Why?
|
| Stem Cells | 1 | 2002 | 3567 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 9583 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15519 | 0.000 |
Why?
|
| Dactinomycin | 1 | 1966 | 318 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2001 | 3712 | 0.000 |
Why?
|
| Leucine | 1 | 1966 | 561 | 0.000 |
Why?
|
| Ferritins | 1 | 1966 | 590 | 0.000 |
Why?
|
| DNA | 1 | 1970 | 7301 | 0.000 |
Why?
|
| Rats | 2 | 1966 | 24260 | 0.000 |
Why?
|
| Liver | 1 | 1966 | 7474 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1966 | 467 | 0.000 |
Why?
|